Design and synthesis of novel cannabinergic analogs with controlled detoxification
Cannabis has been used medicinally and recreationally for several centuries, commonly in the form of the plant's dried leaf/flower ("marijuana"). Δ9- Tetrahydrocannabinol (Δ9-THC) is the primary psychoactive component of cannabis and is prescribed as a pharmaceutical (Dronabinol®) to...
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20002953 |
Similar Items
-
Novel cannabinergic ligands and molecular probes
Published: () -
Novel bicyclic and tricyclic cannabinergic ligands as therapeutic agents
Published: () -
In vitro stability of cannabinergic prodrugs in plasma
by: Pham, Andrew C
Published: (2015) -
Controlled activation and deactivation of cannabinergic ligands and novel mono- and bi-functional classical cannabinoid probes
Published: () -
Interaction between central cannabinergic and serotonergic systems in the rat
by: Overbury, Alison L.
Published: (2004)